A Phase 1, Open Label, Fixed-Sequence Study To Estimate The Effect Of Ketoconazole On The Pharmacokinetics Of Tasocitinib (CP-690,550) In Healthy Volunteers.
Phase of Trial: Phase I
Latest Information Update: 16 Feb 2011
At a glance
- Drugs Ketoconazole; Tofacitinib
- Indications Ankylosing spondylitis; Crohn's disease; Plaque psoriasis; Psoriatic arthritis; Renal transplant rejection; Rheumatoid arthritis; Ulcerative colitis
- Focus Pharmacokinetics; Therapeutic Use
- Sponsors Pfizer
- 16 Feb 2011 Actual end date (Sep 2010) added as reported by ClinicalTrials.gov.
- 16 Feb 2011 Status changed from not yet recruiting to completed as reported by ClinicalTrials.gov.
- 21 Sep 2010 New trial record